ID   BNL 1ME A.7R.1
AC   CVCL_6371
SY   BNL.1ME A.7R.1; BNL 1MEA.7R.1; BNL-HCC
DR   BTO; BTO:0005675
DR   CLO; CLO_0002009
DR   ATCC; TIB-75
DR   BCRC; 60215
DR   CCRID; 1101MOU-PUMC000273
DR   CCRID; 1101MOU-PUMC000326
DR   Wikidata; Q54797670
RX   PubMed=723934;
RX   PubMed=9667749;
RX   PubMed=23796475;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Characteristics: Tumorigenic; forms tumors in BALB/c mice and ATxFL mice (ATCC=TIB-75).
CC   Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Misspelling: TIB75; Note=Based on the ATCC catalog number.
CC   Derived from site: In situ; Embryonic liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4383 ! BNL CL.2
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 18
//
RX   PubMed=723934; DOI=10.1038/276510a0;
RA   Patek P.Q., Collins J.L., Cohn M.;
RT   "Transformed cell lines susceptible or resistant to in vivo
RT   surveillance against tumorigenesis.";
RL   Nature 276:510-511(1978).
//
RX   PubMed=9667749; DOI=10.1093/carcin/19.6.1093;
RA   Gonzales A.J., Goldsworthy T.L., Fox T.R.;
RT   "Chemical transformation of mouse liver cells results in altered
RT   cyclin D-CDK protein complexes.";
RL   Carcinogenesis 19:1093-1102(1998).
//
RX   PubMed=23796475; DOI=10.1016/j.jhep.2013.06.010;
RA   Kapanadze T., Gamrekelashvili J., Ma C., Chan C., Zhao F., Hewitt S.M.,
RA   Zender L., Kapoor V., Felsher D.W., Manns M.P., Korangy F.,
RA   Greten T.F.;
RT   "Regulation of accumulation and function of myeloid derived suppressor
RT   cells in different murine models of hepatocellular carcinoma.";
RL   J. Hepatol. 59:1007-1013(2013).
//